TipRanks
Lavipharm S.A. (DE:BXA0)
FRANKFURT:BXA0
Germany Market
BXA0
Lavipharm S.A.
RESEARCH TOOLSreports

Lavipharm S.A. (BXA0) Income Statement

0 Followers

Lavipharm S.A. Income Statement

Last quarter (Q2 2026), Lavipharm S.A.'s total revenue was €34.44M, an increase of 30.91% from the same quarter last year. In Q2, Lavipharm S.A.'s net income was €2.38M. See Lavipharm S.A.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 62.58M€ 52.95M€ 50.93M€ 39.06M€ 39.72M
Gross Profit
€ 28.80M€ 23.73M€ 23.20M€ 16.38M€ 14.69M
Operating Expenses
€ 21.64M€ 19.48M€ 19.01M€ 13.69M€ 15.09M
Depreciation and Amortization
€ 5.21M€ 4.58M€ 4.21M€ 1.71M€ 1.65M
EBITDA
€ 12.38M€ 10.27M€ 9.73M€ 5.60M€ 6.23M
Operating Income
€ 7.16M€ 4.26M€ 4.18M€ 2.69M€ -398.00K
Other Income/Expenses
€ 343.00K€ -653.00K€ -934.00K€ -433.00K€ 3.15M
Pretax Income
€ 7.50M€ 3.60M€ 3.25M€ 2.26M€ 2.75M
Net Income
€ 5.99M€ 8.98M€ 1.87M€ 834.00K€ 1.72M
Per Share Metrics
Basic EPS
€ 0.04€ 0.05€ 0.01€ 0.04€ 0.09
Diluted EPS
€ 0.04€ 0.05€ 0.01€ 0.04€ 0.09
Weighted Average Shares Outstanding
 169.21M 168.26M 167.87M 21.53M 18.29M
Weighted Average Shares Outstanding (Diluted)
 169.21M 168.50M 168.21M 21.53M 18.29M
Currency in EUR

Lavipharm S.A. Earnings and Revenue History